Unicorn Nest Logo

re.Mind Capital

remind.vc
Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

20

Average round size

36M

Portfolio companies

17

Rounds per year

5.00

Lead investments

1

Follow on index

0.15

Areas of investment
BiotechnologySoftwareArtificial IntelligenceMachine LearningHealth CareHealth DiagnosticsMedical DeviceMedicalNeuroscienceTherapeutics

Investor highlights

Industry focus
Consumer/RetailBiotech/Life SciencesAnalyticsAI/Big Data
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
20
Lead investments
1
Rounds per year
5.00
Follow on index
0.15
Investments by industry
  • Biotechnology (8)
  • Health Care (8)
  • Medical (5)
  • Medical Device (5)
  • Neuroscience (4)
    • Show 19 more
Investments by region
  • United States (14)
  • United Kingdom (3)
  • Germany (1)
  • Switzerland (1)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
5
Group Appearance index
0.95

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Delix Therapeutics 27 Sep 2021 Biotechnology Early Stage Venture 70M United States, Massachusetts, Boston
iLoF - Intelligent Lab on Fiber 28 Jul 2022 Biotechnology, Artificial Intelligence, Machine Learning, Health Care, Health Diagnostics, Medical Device Seed 4M England, Oxford, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.